Related Experiment Video
Updated: Jul 10, 2026
09:53
An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus
Published on: August 25, 2017
HIV-associated Kaposi sarcoma: pathogenesis and therapy
Anja Potthoff1, Norbert H Brockmeyer
1Department of Dermatology and Allergy, St. Josef Hospital, Ruhr-University Bochum, Germany.
Summary
AIDS-related Kaposi sarcoma is aggressive but treatable with chemotherapy and antiretroviral therapy. Local treatments and interferon-alpha can induce remission, with new therapies targeting angiogenesis.
Area of Science:
- Oncology
- Immunology
- Infectious Diseases
Background:
- Classical Kaposi sarcoma progresses slowly, whereas AIDS-related Kaposi sarcoma is highly aggressive.
- Antiretroviral therapy and chemotherapy have improved outcomes for AIDS-related Kaposi sarcoma.
- Understanding pathogenesis is key to developing novel therapeutic targets.
Purpose of the Study:
- To review current and emerging therapeutic strategies for Kaposi sarcoma, particularly AIDS-related cases.
- To highlight the efficacy of various treatment modalities.
- To discuss new therapeutic targets based on disease pathogenesis.
Main Methods:
- Review of existing literature on Kaposi sarcoma treatment.
- Analysis of therapeutic options including local treatments and systemic therapies.
- Discussion of novel therapeutic targets like angiogenesis inhibition.
Main Results:
- Complete remission is achievable with antiretroviral therapy and chemotherapy.
- Local therapies (excision, cryosurgery, radiation, alitretinoin gel) are viable options.
- Interferon-alpha induces complete remission in 45% of patients with CD4+ counts >400/microl.
Conclusions:
- Aggressive Kaposi sarcoma, especially AIDS-related, can be effectively managed with current therapies.
- Local treatments and systemic agents like interferon-alpha offer significant remission rates.
- Targeting angiogenesis presents a promising avenue for future Kaposi sarcoma treatment.
Related Concept Videos
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:26Sexually Transmitted Infections
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:51Mechanisms of Retrovirus-induced Cancers
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...